CD4⁺ CD28⁺ lymphocytes on day 5 after high-dose melphalan for multiple myeloma predict a low risk of infections during severe neutropenia and are associated with the number of reinfused T lymphocytes of the autologous stem cell graft

References

• Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibet JG, Rossi JF, . A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. N Engl J Med. 1996;335:91–7.
   PubMed Web of Science ®Google Scholar
• Barlogie B, Jagannath S, Desikan KR, Mattox S, Vesole D, Siegel D, . Total therapy with tandem transplants for newly diagnosed multiple myeloma. Blood. 1999;93: 55–65.
   PubMed Web of Science ®Google Scholar
• Child JA, Morgan GJ, Davies FE, Owen RG, Bell SE, Hawkins K, . High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med. 2003;348: 1875–83.
   PubMed Web of Science ®Google Scholar
• Attal M, Harousseau JL, Facon T, Guilhot F, Doyen C, Fuzibet JG, . Single versus double autologous stem-cell transplantation for multiple myeloma. N Engl J Med. 2003; 349:2495–502.
   PubMed Web of Science ®Google Scholar
• Palumbo A, Bringhen S, Petrucci MT, Musto P, Rossini F, Nunzi M, . Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial. Blood. 2004;104:3052–7.
   PubMed Web of Science ®Google Scholar
• Furno P, Bucaneve G, Del Favero A. Monotherapy or aminoglycoside-containing combinations for empirical antibiotic treatment of febrile neutropenic patients: a meta-analysis. Lancet Infect Dis. 2002;2:231–42.
   PubMed Web of Science ®Google Scholar
• Dekker A, Bulley S, Beyene J, Dupuis LL, Doyle JJ, Sung L. Meta-analysis of randomized controlled trials of prophylactic granulocyte colony-stimulating factor and granulocyte–macrophage colony-stimulating factor after autologous and allogeneic stem cell transplantation. J Clin Oncol. 2006; 24:5207–15.
   PubMed Web of Science ®Google Scholar
• Berghmans T, Paesmans M, Lafitte JJ, Mascaux C, Meert AP, Jacquy C, . Therapeutic use of granulocyte and granulocyte–macrophage colony-stimulating factors in febrile neutropenic cancer patients. A systematic review of the literature with meta-analysis. Support Care Cancer. 2002;10:181–8.
   PubMed Web of Science ®Google Scholar
• Castagnola E, Faraci M. Management of bacteremia in patients undergoing hematopoietic stem cell transplantation. Expert Rev Anti Infect Ther. 2009;7:607–21.
   PubMed Web of Science ®Google Scholar
• Beekman R, Touw IP. G-CSF and its receptor in myeloid malignancy. Blood. 2010;115:5131–36.
   PubMed Web of Science ®Google Scholar
• Eleutherakis-Papaiakovou E, Kostis E, Migkou M, Christoulas D, Terpos E, Gavriatopoulou M, . Prophylactic antibiotics for the prevention of neutropenic fever in patients undergoing autologous stem-cell transplantation: results of a single institution, randomized phase 2 trial. Am J Hematol. 2010;85: 863–7.
   PubMed Web of Science ®Google Scholar
• Pascoe J, Steven N. Antibiotics for the prevention of febrile neutropenia. Curr Opin Hematol. 2009;16:48–52.
   PubMed Web of Science ®Google Scholar
• Hiwase DK, Hiwase S, Bailey M, Bollard G, Schwarer AP. The role of stem cell mobilization regimen on lymphocyte collection yield in patients with multiple myeloma. Cytotherapy. 2008;10:507–17.
   PubMed Web of Science ®Google Scholar
• Hiwase DK, Hiwase S, Bailey M, Bollard G, Schwarer AP. Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma. Biol Blood Marrow Transplant. 2008;14: 116–24.
   PubMed Web of Science ®Google Scholar
• Porrata LF, Markovic SN. Timely reconstitution of immune competence affects clinical outcome following autologous stem cell transplantation. Clin Exp Med. 2004;4:78–85.
   PubMed Web of Science ®Google Scholar
• Schmidmaier R, Oversohl N, Schnabel B, Straka C, Emmerich B. Helper T cells (CD3+/CD4+) within the autologous peripheral blood stem cell graft positively correlate with event free survival of multiple myeloma patients. Exp Oncol. 2008;30: 240–3.
   PubMedGoogle Scholar
• Schnabel B, Schmidmaier R, Franke D, Emmerich B, Straka C. Correlation of residual leukocyte subsets with neutropenic fever during severe leukopenia after high-dose chemotherapy and autologous stem cell transplantation. Cytotherapy. 2006;8: 473–9.
   PubMed Web of Science ®Google Scholar
• Kassar M, Medoff E, Seropian S, Cooper DL. Outpatient high-dose melphalan in multiple myeloma patients. Transfusion. 2007;47:115–19.
   PubMed Web of Science ®Google Scholar
• Tricot G, Jagannath S, Vesole D, Nelson J, Tindle S, Miller L, . Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood. 1995;85:588–96.
   PubMed Web of Science ®Google Scholar
• Ketterer N, Salles G, Raba M, Espinouse D, Sonet A, Tremisi P, . High CD34+cell counts decrease hematologic toxicity of autologous peripheral blood progenitor cell transplantation. Blood. 1998;91:3148–55.
   PubMed Web of Science ®Google Scholar
• Weaver CH, Hazelton B, Birch R, Palmer P, Allen C, Schwartzberg L, . An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood. 1995;86:3961–9.
   PubMed Web of Science ®Google Scholar
• Gorschlüter M, Glasmacher A, Sarazin S, Hackbarth F, Hoebert E, Orlopp K, . CD4+ T lymphocyte counts after autologous transplantation in multiple myeloma: a retrospective study. Leuk Lymphoma. 2007;48:506–12.
   PubMed Web of Science ®Google Scholar
• Kim DH, Kim JG, Sohn SK, Sung WJ, Suh JS, Lee KS, . Clinical impact of early absolute lymphocyte count after allogeneic stem cell transplantation. Br J Haematol. 2004;125: 217–24.
   PubMed Web of Science ®Google Scholar
• Einsele H, Ehninger G, Steidl M, Fischer I, Bihler S, Gerneth F, . Lymphocytopenia as an unfavorable prognostic factor in patients with cytomegalovirus infection after bone marrow transplantation. Blood. 1993;82:1672–8.
   PubMed Web of Science ®Google Scholar
• Zambelli A, Montagna D, Da Prada GA, Maccario R, Zibera C, Moretta A, . Evaluation of infectious complications and immune recovery following high-dose chemotherapy (HDC) and autologous peripheral blood progenitor cell transplantation (PBPC-T) in 148 breast cancer patients. Anticancer Res. 2002;22:3701–8.
   PubMed Web of Science ®Google Scholar
• van der Velden WJ, Blijlevens NM, Feuth T, Donnelly JP. Febrile mucositis in haematopoietic SCT recipients. Bone Marrow Transplant. 2009;43:55–60.
   PubMed Web of Science ®Google Scholar
• Menichetti F. Infectious complications in neutropenic cancer patients. Intern Emerg Med. 2010;5(Suppl 1):S21–5.
   Google Scholar
• Monsuez JJ, Carcelain G, Charniot JC, Barrière J, Duclos-Vallée JC, Parent F, . T cells subtypes in a patient with interferon-alpha induced sarcoidosis. Am J Med Sci. 2009; 337:60–2.
   PubMedGoogle Scholar
• García de Tena J, Manzano L, Leal JC, San Antonio E, Sualdea V, Alvarez-Mon M. Active Crohn's disease patients show a distinctive expansion of circulating memory CD4+ CD45RO+ CD28null T cells. J Clin Immunol. 2004;24: 185–96.
   PubMed Web of Science ®Google Scholar
• Chen BJ, Cui X, Sempowski GD, Domen J, Chao NJ. Hematopoietic stem cell dose correlates with the speed of immune reconstitution after stem cell transplantation. Blood. 2004; 103:4344–52.
   PubMed Web of Science ®Google Scholar
• Straka C, Oduncu F, Hinke A, Einsele H, Drexler E, Schnabel B, . Responsiveness to G-CSF before leukopenia predicts defense to infection in high-dose chemotherapy recipients. Blood. 2004;104:1989–94.
   PubMed Web of Science ®Google Scholar
• Hui EP, Leung LK, Poon TC, Mo F, Chan VT, Ma AT, . Prediction of outcome in cancer patients with febrile neutropenia: a prospective validation of the Multinational Association for Supportive Care in Cancer risk index in a Chinese population and comparison with the Talcott model and artificial neural network. Support Care Cancer. in press; Published online: 4 September 2010.
   Google Scholar
• Hui EP, Leung LK, Poon TC, Mo F, Chan VT, Ma AT, Poon A, Hui EK, Mak SS, Lai M, Lei KI, Ma BB, Mok TS, Yeo W, Zee BC, Chan AT. Prediction of outcome in cancer patients with febrile neutropenia: a prospective validation of the Multinational Association for Supportive Care in Cancer risk index in a Chinese population and comparison with the Talcott model and artificial neural network. Support Care Cancer. in press; Published online: 4 September 2010.
   Google Scholar
• Condomines M, Quittet P, Lu Z-Y, Nadal L, Latry P, Lopez E, . Functional regulatory T cells are collected in stem cell autografts by mobilization with high-dose cyclophosphamide and granulocyte colony-stimulating factor. J Immunol. 2006;176:6631–9.
   PubMed Web of Science ®Google Scholar